Combined KCAS, FlowMetric & Active Biomarkers offer for bioanalytical services.
The group provides comprehensive, regulated (GLP/GCP compliant) bioanalytical services to the global biopharmaceutical industry from early discovery support through product registration and beyond.
What do all innovative therapies under development have in common? Whether in preclinical or clinical stage, they all need robust and reliable biomarker assays, sound PK-PD methods and frequently immunogenicity assessments. Active Biomarkers is an integrated laboratory bringing decades of experience in the development, validation, and implementation of analytical methods. Its know-how is recognized in 4 major therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. Beyond its state-of-the-art flow cytometry and ELISpot capabilities, Active Biomarkers offers the broadest panel of immunoassay technologies ranging from standard ELISA to multiplexed methods such as Luminex, SP-X, Gyros or ELLA systems, and ultra-sensitive technologies such as MSD or Simoa. Learn more here: www.active-biomarkers.com